Publication | Closed Access

Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryArthritis-interstitial Lung DiseaseInflammatory Lung DiseaseAutoimmune DiseaseMedicineSystemic TreatmentImmunologyOsteoarthritisChronic InflammationInflammatory Rheumatic DiseaseReactive Oxygen SpeciePharmacologyRheumatoid ArthritisResveratrol AlleviatesOxidative Stress